Cargando…
N-hexanoyl-sphingomyelin potentiates in vitro doxorubicin cytotoxicity by enhancing its cellular influx
Anticancer drugs generally have intracellular targets, implicating transport over the plasma membrane. For amphiphilic agents, such as the anthracycline doxorubicin, this occurs by passive diffusion. We investigated whether exogenous membrane-permeable lipid analogues improve this drug influx. Combi...
Autores principales: | Veldman, R J, Zerp, S, van Blitterswijk, W J, Verheij, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410169/ https://www.ncbi.nlm.nih.gov/pubmed/14970874 http://dx.doi.org/10.1038/sj.bjc.6601581 |
Ejemplares similares
-
The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro
por: Abou El Hassan, M A I, et al.
Publicado: (2003) -
A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin
por: Tang, H-J, et al.
Publicado: (2004) -
A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro
por: Abou El Hassan, M A I, et al.
Publicado: (2003) -
N-hexanoyl chitosan stabilized magnetic nanoparticles: Implication for cellular labeling and magnetic resonance imaging
por: Bhattarai, Shanta R, et al.
Publicado: (2008) -
Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro
por: Koch, S, et al.
Publicado: (2003)